|Last Price$13.01||Day Change (%)0.31%|
|Open Price$13.01||Day Change ($)0.04|
|Day Range13.01–13.01||52-Week Range12.37–13.30|
As of Wed 06/29/2016 | USD
LYNPARZA (olaparib): Latest Data Suggest Potential Overall Survival Advantage in Patients with Platinum Sensitive Ovarian Cancer
Pixium Vision Receives Clinical Trial Approval from UK Regulatory Authority for 150 Electrode IRIS®II Bionic Vision System
Mid-caps and energy lead the way; growth shows signs of life.